Creative Biogene Released Plasmid DNA CDMO Service to Support AAV and Lentiviral Vector Production

Creative Biogene announced the release of its plasmid DNA CDMO services to support AAV lentiviral vector production, mRNA in vitro transcription, and direct gene transfer.

USA – January 30, 2023 /MarketersMEDIA/ —

Creative Biogene, the leading biotechnology products and services provider, is dedicated to providing vaccine-, bio-, cell- and gene-therapy development manufacturing services. With years of experience and a professional platform, Creative Biogene develops and produces products, kits and reaction mixes for scientists to apply in their molecular biology assays, diagnostic tests and commercialization of new drugs. Recently, Creative Biogene announced the release of its plasmid DNA CDMO services to support AAV lentiviral vector production, mRNA in vitro transcription, and direct gene transfer.

Starting with high-quality raw materials early helps shorten the time and reduces the risk of duplication of work due to material changeovers and inconsistent material quality. Creative Biogene’s plasmid DNA CDMO service can fill the gap by delivering high-quality plasmid DNA with high lot-to-lot consistency. 

Creative Biogene has extensive experience and expertise in the large-scale production of plasmid DNA for a variety of applications, producing GMP plasmid DNA starting material for the production of viral vectors (e.g. lentivirus and AAV) or in vitro transcribed RNA (IVT-RNA) (e.g. mRNA, long RNA). Creative Biogene also produces plasmid DNA APIs for use as DNA vaccines or therapeutic non-viral plasmid DNA-mediated gene therapy applications.

Creative Biogene has extensive experience in the production and quality control of difficult-to-produce plasmid DNA, such as sequences containing repeated genes of interest, inverted terminal repeats (ITRs), long terminal repeats (LTRs), or polyA tails. Creative Biogene’s large-scale plasmid manufacturing capabilities are of particular interest in reducing the commodity cost of helper plasmids that can be used in multiple viral vector production projects.

Creative Biogene provides expertise in the development and GMP manufacturing of non-viral DNA vectors for research use. And a 200g scale plasmid DNA API has been produced using a 350L working volume fermenter, with plans to expand to a kg scale.

“Besides, our bioproduction cell line development services can help you establish a solid foundation for the successful development and manufacture of biologics.” said Marcia Brady, the marketing director of Creative Biogene, she also added, “We can provide customized molecular biology reagents and professional technical services to customers in the life science research field.”

About Creative Biogene

Creative Biogene is a top-of-its-kind company that holds a leading position and is committed to accelerating the development of human science through biotechnology, offering innovative technologies, products, unique tools and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader to support researchers worldwide.

Contact Info:
Name: Marcia Brady
Email: Send Email
Organization: Creative Biogene
Address: Shirley, NY 11967, USA
Phone: 6313868241
Website: https://www.creative-biogene.com/

Release ID: 89089259

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.